# Emergent BioSolutions Inc.: Form 8-K/A, filed Dec 12, 2018

- Company: [Emergent BioSolutions Inc.](/companies/ebs.md) (CIK 1367644)
- Form: 8-K/A
- Filed: 2018-12-12
- Accepted by EDGAR: Dec 12, 2018, 16:16 ET
- Period: 2018-10-15
- Accession: 0001104659-18-072552
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1367644/000110465918072552/a18-40859_28ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1367644/000110465918072552/

## Items reported

- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1367644/000110465918072552/a18-40859_28ka.htm

Filed Dec 12, 2018.
Source: SEC EDGAR, the filing index for accession 0001104659-18-072552. Last ingested by Listed: Nov 4, 2026, 16:51 ET. No prices; not investment advice.
